1. Home
  2. VIPS vs HALO Comparison

VIPS vs HALO Comparison

Compare VIPS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vipshop Holdings Limited

VIPS

Vipshop Holdings Limited

N/A

Current Price

$17.25

Market Cap

9.1B

ML Signal

N/A

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$78.54

Market Cap

8.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VIPS
HALO
Founded
2008
1998
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
8.8B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
VIPS
HALO
Price
$17.25
$78.54
Analyst Decision
Buy
Buy
Analyst Count
4
12
Target Price
$19.83
$76.42
AVG Volume (30 Days)
2.2M
1.8M
Earning Date
02-20-2026
02-18-2026
Dividend Yield
2.77%
N/A
EPS Growth
N/A
56.68
EPS
1.94
4.74
Revenue
$14,983,370,343.00
$1,242,852,000.00
Revenue This Year
$0.62
$34.54
Revenue Next Year
$2.32
$26.28
P/E Ratio
$8.93
$16.56
Revenue Growth
N/A
31.19
52 Week Low
$12.14
$47.50
52 Week High
$21.08
$79.50

Technical Indicators

Market Signals
Indicator
VIPS
HALO
Relative Strength Index (RSI) 45.79 70.10
Support Level $16.73 $71.23
Resistance Level $18.01 $79.39
Average True Range (ATR) 0.46 2.27
MACD 0.04 0.68
Stochastic Oscillator 61.54 94.02

Price Performance

Historical Comparison
VIPS
HALO

About VIPS Vipshop Holdings Limited

Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts ranging from 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurements, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with global brand partners . As of March 31, 2025, Eric Ya Shen, chairman and CEO, had 64.5% voting rights. Leading Chinese social media firm and strategic shareholder Tencent also holds an 12.5% interest.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: